A B c A B c ER-class KFGG p.1thwo:~y Mb05221;Aeute mye-lOid le-ukemia hsa04070:Phospht1t'clytlnot;lt01 ~;lgnt1llngsystem h&e00562:1no&ltol phoe~temeu.botl&m 0.001386 P IP5 K2A . IP"-tK, P IP5K 1C, P1K3CG, PIK4C.B h~5215:Pro!l-t:t.te cancer 0 .001395 AR~f1, POGFRA, MAPKI. IKBKB, PIK3CG, Raft hsa049 10:1n sulin signaling pathway hs.a05214:Giiom;:~ hsa04010:MAPK signa ling pathway h9a04810:Reg\M.Iti01'1 otactin cytoskeleton Ma05218:Mei81'M)m8 hM'0$212:P~etltic CE~noer hsa05220:Ctwonic myeloid leukemia h~0$210:Colorect<ll wnoer Mb04930:T~11 diebetee mellitus P-vilhlll't 1.65E.Q4 7.$4E-04 0 .001662 0.002.538 0.002956 0.00405 0.004225 0 .00$173 0 .00543 0 .006&48 0 .00914 G l9n e"' ARafl, Pim1, MAPK1. IKBKB. PIK3CG, Rafl PIP$K2A. OGKZ. P IP5K t C, P IIQCG, P IK4CB, DGKO PRKCZ.. ARafl , MAPK 1, IKBK B, P IK3CG, Rart, PRKACG AR;;~fl, POGFRA, MAPK1, PIK3CG, Ra f 1, MAPK12, POGFRA, MAPK1. IKBKB. R8f1, MA.P3K t, PRI<ACG, MAPK81P3, MAP3K t 2 P1P5K2A, ARaft , PIP5K1C, POGFRA, MAPK1 , PIK3CG, Rllf1 , A:OCK2 ARafl, POGFRA. MAPKl , PIK3CG, R.ar1 AAtlf1, MAPt<1, IKS-KB, Pn<3CG. R;:1f1 ARaf1, MAPK1, IKBKB, PIK3CG, Raf1 AAtlf1, POGFAA, MAPt<1, PIK3CG. R<af 1 PRKCZ. MAPK1, IKBKB, PIK3CG Mixed-class K~GG P"lhw;::~y ... v.,.l uc Gcn<H> hso:~OOS62':1no51tol phosphi:lt.o mct;;a.bolism 3.40Eá04 PtK4CA,INPP4B, SYNJ t, PIP6K2C hs.a04070:Phos.pha tidytin06itol signaling s~em 1.10E.OO PIK4CA,INPP4B, SVNJ1, PIP5K2C Golgi-class 